Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables

Abstract

Genetic profiling of patients with RRD can improve the predictability of PVR in addition to the well-known clinical biomarkers. This validated formula could be a new tool in our current clinical practice in order to identify those patients at high risk of developing PVR.